Chemical identity

Rifamycin Y

CAS 15271-73-5 · C39H47NO15

01Identity

Identifiers and names for this exact compound. Empty fields are left unassigned.

Lazychem IDLC-26986
PubChem CID6916298
NameRifamycin Y
CAS RN15271-73-5
Molecular formulaC39H47NO15
Molecular weight769.8 g/mol
IUPAC name4-O-(Carboxymethyl)-21-deoxy-20-hydroxy-21-oxorifamycin; Acetic acid, [(1,2-dihydro-5,6,16,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11,17-trioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-, 21-acetate
InChIKeyWVPVVIOXGMSGRF-AYDMIGIISA-N

02Structure identifiers

2D structurePubChem CID 6916298
Two-dimensional chemical structure of Rifamycin Y, CAS 15271-73-5
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon. These statements are calculated from the published structure string.

Defined stereocentres0
Unassigned stereocentres8
Ring count5
Secondary amines0
Tertiary amines0
N-methyl amine sites0
SMILESCC1C(/C=C\OC2(C(=O)C3=C(O2)C(=C(C4=C(C(=CC(=C43)OCC(=O)O)NC(=O)/C(=C\C=C/C(C(=O)C(C(C(C1OC(=O)C)C)O)C)(C)O)/C)O)O)C)C)OC
InChINot listed
Formula from structureC39H47NO15
Molecular weight from structure769.8 g/mol

03Stereochemistry

The published structure contains 0 defined and 8 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres8Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 256Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04India status for this compound

These results apply only to this exact compound name and CAS number. Confirm the current official instruments before making a regulatory decision.

NDPS / RCSNO EXACT MATCH FOUNDCAS 15271-73-5 has no exact match in the reviewed published schedule.
SCOMETNO EXACT REVIEWED CAS MATCHCAS 15271-73-5 has no exact match in the reviewed SCOMET list.
Review date2026-08-01Recheck the current official instruments for the material, concentration, activity and date in question.

05Names and relationships

Associated parent compound

Rifamycin

View API and impurity family

Other names

  • Rifamycin, 4-O-(carboxymethyl)-21-deoxy-20-hydroxy-21-oxo
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv
  • 2-[[(9Z,19Z,21Z)-13-Acetyloxy-2,15,18,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,17,23-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-yl]oxy]acetic acid
  • 15271-73-5
  • NSC145655
  • 4-O-Carboxymethyl-21-deoxy-20-hydroxy-21-oxorifamycin
  • DTXSID60426025
  • {[(12Z,14Z,24Z)-21-(Acetyloxy)-5,6,16,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11,17-trioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yl]oxy}acetic acid

Related records from the same parent family

06Documented history

Dated discovery, occurrence, use and issue claims are published only when a suitable primary or government source is available.

No dated history available

No verified discovery, first report, occurrence, use or issue event is currently available for this identity.

07Sources